Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. (Q34590731)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. |
scientific article |
Statements
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study (English)
Stephen Clarke
Werner Scheithauer
Arie Figer
Ralph Wong
Sheryl Koski
Mikhail Lichinitser
Tsai-Shen Yang
Fernando Rivera
Felix Couture
Florin Sirzén